Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Inhibitors

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Image of 2D Structure
Search for synonyms (with exact matching search term)

Search term:

Results 1 - 10 of 286 > >>
EC Number Inhibitors Commentary Structure
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.7(10S,13S)-10-(1H-indol-3-ylmethyl)-8,11-dioxo-N-(4-oxotetrahydrofuran-3-yl)-2-oxa-9,12-diazabicyclo[13.2.2]nonadeca-1(17),15,18-triene-13-carboxamide - Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.7(12S,15S)-12-(1H-indol-3-ylmethyl)-10,13-dioxo-N-(4-oxotetrahydrofuran-3-yl)-2-oxa-11,14-diazabicyclo[15.2.2]henicosa-1(19),17,20-triene-15-carboxamide - Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.7(4-[2-[(4-aminomethyl-cyclohexanecarbonyl)-amino]-3-phenyl-propionylamino]-phenyl)-acetic acid IC50 in reaction with D-Val-Leu-Lys-4-nitroanilide is 0.63 mM Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.7(9S,12S)-9-(1H-indol-3-ylmethyl)-7,10-dioxo-N-(4-oxotetrahydrofuran-3-yl)-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxamide - Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.7(E)-5,5'-(but-2-ene-1,4-diylbis(oxy))bis(2-(3,4-O,O-disulfonato-phenyl)-3,7-O,O-disulfonato-4Hchromen-4-one about 43% residual activity at 0.4 mM Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.72-(3-[3-[(6-amino-hexyl)-(2-benzyloxycarbonylamino-3-phenyl-propionyl)-amino]-2-oxo-cyclohexyl]-propionylamino)-3-(1H-indol-3-yl)-propionic acid methyl ester IC50: 0.024 mM Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.72-[(4-Aminomethyl-cyclohexanecarbonyl)-amino]-3-[4-(2-bromo-benzyloxycarbonyloxy)-phenyl]-propionic acid pyridin-2-ylmethyl ester IC50 in reaction with D-Val-Leu-Lys-4-nitroanilide is 0.0042 mM Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.72-[3-(3-[(6-amino-hexyl)-[2-benzyloxycarbonylamino-3-(1H-indol-3-yl)-propionyl]-amino]-2-oxo-cyclohexyl)-propionylamino]-3-(1H-indol-3-yl)-propionic acid methyl ester IC50: 0.02 mM Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.73-(8-(4-((2-(3,4-O,O-disulfonato-phenyl)-3,7-O,O-disulfonato-4-oxo-4H-chromen-5-yloxy)methyl)-1H-1,2,3-triazol-1-yl)heptyl)-2-(4-O-sulfonato-phenyl)quinazolin-4(3H)-one about 1% residual activity at 0.4 mM Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.73-(8-(4-((2-(3,4-O,O-disulfonato-phenyl)-3,7-O,O-disulfonato-4-oxo-4H-chromen-5-yloxy)methyl)-1H-1,2,3-triazol-1-yl)octyl)-2-(4-O-sulfonato-phenyl)quinazolin-4(3H)-one about 2% residual activity at 0.4 mM Go to the Ligand Summary Page
Results 1 - 10 of 286 > >>